Bluewater Bio's Series C Round

Bluewater Bio raised a round of funding on November 04, 2011. Investors include Liberation Capital.

Bluewater Bio is in the wastewater treatment business, providing a wastewater treatment process, called HYBACS. Per the company, HYBACS, denoting Hybrid Bacillus Activated Sludge, treats a wide range …

Articles about Bluewater Bio's Series C Round: